These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3462001)

  • 1. A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus.
    Bösze Z; Thiesen HJ; Charnay P
    EMBO J; 1986 Jul; 5(7):1615-23. PubMed ID: 3462001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
    Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
    J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus.
    Chatis PA; Holland CA; Silver JE; Frederickson TN; Hopkins N; Hartley JW
    J Virol; 1984 Oct; 52(1):248-54. PubMed ID: 6090701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers.
    Thiesen HJ; Bösze Z; Henry L; Charnay P
    J Virol; 1988 Feb; 62(2):614-8. PubMed ID: 2826819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.
    Chatis PA; Holland CA; Hartley JW; Rowe WP; Hopkins N
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4408-11. PubMed ID: 6308622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
    Feuer G; Fan H
    J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
    Manley NR; O'Connell MA; Sharp PA; Hopkins N
    J Virol; 1989 Oct; 63(10):4210-23. PubMed ID: 2778872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
    Fan H; Mittal S; Chute H; Chao E; Pattengale PK
    J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
    Baum C; Eckert HG; Stocking C; Ostertag W
    Exp Hematol; 1996 Feb; 24(2):364-70. PubMed ID: 8641367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses.
    Sitbon M; Ellerbrok H; Pozo F; Nishio J; Hayes SF; Evans LH; Chesebro B
    J Virol; 1990 May; 64(5):2135-40. PubMed ID: 2182908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The envelope gene and long terminal repeat sequences contribute to the pathogenic phenotype of helper-independent Friend viruses.
    Oliff A; Signorelli K; Collins L
    J Virol; 1984 Sep; 51(3):788-94. PubMed ID: 6088801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
    Golemis E; Li Y; Fredrickson TN; Hartley JW; Hopkins N
    J Virol; 1989 Jan; 63(1):328-37. PubMed ID: 2783259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses.
    Vogt M; Haggblom C; Swift S; Haas M
    J Virol; 1985 Jul; 55(1):184-92. PubMed ID: 4009793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.
    Overhauser J; Fan H
    J Virol; 1985 Apr; 54(1):133-44. PubMed ID: 2983110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long terminal repeat of Friend-MCF virus contains the sequence responsible for erythroid leukemia.
    Ishimoto A; Adachi A; Sakai K; Matsuyama M
    Virology; 1985 Feb; 141(1):30-42. PubMed ID: 3856371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced expression from the Moloney murine leukemia virus long terminal repeat during differentiation of human myeloid cells is mediated through its transcriptional enhancer.
    Reisman D; Rotter V
    Mol Cell Biol; 1989 Aug; 9(8):3571-5. PubMed ID: 2477690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
    Fan H; Chute H; Chao E; Pattengale PK
    Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
    Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
    J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.
    Li Y; Golemis E; Hartley JW; Hopkins N
    J Virol; 1987 Mar; 61(3):693-700. PubMed ID: 3468264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.